morphiceptin, n-me-phe(3)- has been researched along with beta-funaltrexamine in 2 studies
Studies (morphiceptin, n-me-phe(3)-) | Trials (morphiceptin, n-me-phe(3)-) | Recent Studies (post-2010) (morphiceptin, n-me-phe(3)-) | Studies (beta-funaltrexamine) | Trials (beta-funaltrexamine) | Recent Studies (post-2010) (beta-funaltrexamine) |
---|---|---|---|---|---|
95 | 1 | 1 | 542 | 1 | 54 |
Protein | Taxonomy | morphiceptin, n-me-phe(3)- (IC50) | beta-funaltrexamine (IC50) |
---|---|---|---|
Muscarinic acetylcholine receptor M2 | Rattus norvegicus (Norway rat) | 0.082 | |
Prostaglandin G/H synthase 1 | Homo sapiens (human) | 0.082 | |
Delta-type opioid receptor | Mus musculus (house mouse) | 0.082 | |
Kappa-type opioid receptor | Mus musculus (house mouse) | 0.082 | |
Mu-type opioid receptor | Mus musculus (house mouse) | 0.082 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adapa, ID; Auh, JS; Berzetei-Gurske, IP; Brandt, SR; Craymer, K; Farrington, L; Haggart, D; Kennedy, JM; O'Brien, A; Polgar, WE; Rodriguez, L; Schwartz, RW; Toll, L; White, A | 1 |
Macdonald, RL; Moises, HC; Rusin, KI | 1 |
2 other study(ies) available for morphiceptin, n-me-phe(3)- and beta-funaltrexamine
Article | Year |
---|---|
Standard binding and functional assays related to medications development division testing for potential cocaine and opiate narcotic treatment medications.
Topics: Animals; Aorta, Thoracic; Cocaine; Cyclic AMP; Electric Stimulation; Guinea Pigs; Humans; Ileum; In Vitro Techniques; Male; Mice; Muscle, Smooth; Opioid-Related Disorders; Rats; Receptors, Dopamine; Receptors, Opioid; Receptors, Serotonin; Substance-Related Disorders | 1998 |
Mu- and kappa-opioid receptors selectively reduce the same transient components of high-threshold calcium current in rat dorsal root ganglion sensory neurons.
Topics: Analgesics; Animals; Benzeneacetamides; Calcium; Calcium Channels; Dynorphins; Endorphins; Enkephalin, D-Penicillamine (2,5)-; Enkephalins; Evoked Potentials; Ganglia, Spinal; In Vitro Techniques; Naloxone; Naltrexone; Narcotic Antagonists; Neurons, Afferent; Pyrrolidines; Rats; Receptors, Opioid, kappa; Receptors, Opioid, mu; Reference Values; Sensitivity and Specificity | 1994 |